) The Genetics/Genomics Core is organized to provide both consultation and state-of-the-art technologies and data interpretation in genomics and bioinformatics. Core scientists interact with CCC researchers at the design phase of projects and assist in incorporating genomics approaches by a) generation of preliminary data, b) writing methodologies, c) high throughput implementation of technology, and d) data mining in public and proprietary databases. The Core supports research investigating genetic elements responsible for cancer susceptibility and genetic factors involved in neoplastic initiation and progression. Existing Core technologies include: 1) high-throughput DNA sequencing and genotyping (ABI 3700); 2) real-time quantitative PCR for mRNA and/or DNA (ABI 7700); 3) high-volume microsatellite-repeat genotyping (ABI 377s) and SNP analysis (ABI TaqMan7700); 4) rapid, inexpensive 96-well-based polymorphism/mutation hunting with HPLC heteroduplexing (WAVE); 5) 24-fluor color SKY painting of chromosomes; 6) FISH gene mapping to chromosomes; 7) Comparative Genome Hybridization (CGH); and 8) high throughput robotic assistance in picking and arraying clones, growing large library collections, and general liquid handling; 9) single cell micromanipulation and molecular/cytogenetics; and 10) gene expression profiling using in-house microprinted glass microarrays of the entire (up-to-date UNIGENE) human and rat EST collections. The facility is Certified by federal (CLIA-88), state (DoH), and professional societies (ASHG and CAP) for data integrity. Bioinformatics is a critical component of any genomics and proteomics facility and the Core operates, in partnership with PE-Informatics, software for a) sample acquisition and tracking, correlation with clinical information, work assignment, clone/plate management and raw data reporting (SQL*LIMS & SQL*GT); b) data mining tools (extensive software); and c) systems microarray and sequence analysis (GeneKeeper) and sophisticated publish/subscribe/share capability throughout the CCC (BioMerge). The Core has onsite, a 40-gigabite database of sequence data accessible with these software tools, a UNIX based SGI supercomputer and multiple SUN workstations linked to researchers via a GigaPoP fiber backbone. Bioinformatics personnel include an OS system manager, Oracle databasers, application specialists, and technology-specific project managers.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA022453-22
Application #
6457256
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
1988-04-01
Project End
2002-11-30
Budget Start
Budget End
Support Year
22
Fiscal Year
2001
Total Cost
Indirect Cost
Name
Wayne State University
Department
Type
DUNS #
City
Detroit
State
MI
Country
United States
Zip Code
48202
Herroon, Mackenzie K; Rajagurubandara, Erandi; Diedrich, Jonathan D et al. (2018) Adipocyte-activated oxidative and ER stress pathways promote tumor survival in bone via upregulation of Heme Oxygenase 1 and Survivin. Sci Rep 8:40
Colacino, Justin A; Azizi, Ebrahim; Brooks, Michael D et al. (2018) Heterogeneity of Human Breast Stem and Progenitor Cells as Revealed by Transcriptional Profiling. Stem Cell Reports 10:1596-1609
Blocker, Stephanie J; Shields, Anthony F (2018) Imaging of Nanoparticle Distribution to Assess Treatments That Alter Delivery. Mol Imaging Biol 20:340-351
Guastella, Anthony R; Michelhaugh, Sharon K; Klinger, Neil V et al. (2018) Investigation of the aryl hydrocarbon receptor and the intrinsic tumoral component of the kynurenine pathway of tryptophan metabolism in primary brain tumors. J Neurooncol 139:239-249
Li, Feng; Wang, Yongli; Li, Dapeng et al. (2018) Perspectives on the recent developments with green tea polyphenols in drug discovery. Expert Opin Drug Discov 13:643-660
Ramseyer, Vanesa D; Kimler, Victoria A; Granneman, James G (2018) Vacuolar protein sorting 13C is a novel lipid droplet protein that inhibits lipolysis in brown adipocytes. Mol Metab 7:57-70
Healy, Mark A; Morris, Arden M; Abrahamse, Paul et al. (2018) The accuracy of chemotherapy ascertainment among colorectal cancer patients in the surveillance, epidemiology, and end results registry program. BMC Cancer 18:481
Lacher, Sarah E; Alazizi, Adnan; Wang, Xuting et al. (2018) A hypermorphic antioxidant response element is associated with increased MS4A6A expression and Alzheimer's disease. Redox Biol 14:686-693
Alsaab, Hashem O; Sau, Samaresh; Alzhrani, Rami M et al. (2018) Tumor hypoxia directed multimodal nanotherapy for overcoming drug resistance in renal cell carcinoma and reprogramming macrophages. Biomaterials 183:280-294
Chammaa, May; Malysa, Agnes; Redondo, Carlos et al. (2018) RUMI is a novel negative prognostic marker and therapeutic target in non-small-cell lung cancer. J Cell Physiol 233:9548-9562

Showing the most recent 10 out of 826 publications